Inhibition of the mammalian target of rapamycin leads to autophagy activation and cell death of MG63 osteosarcoma cells

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1465-1469

  Xie, Zong Gang ^a   Xie, Ye ^a   Dong, Qi Rong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Autophagy; Chemotherapy; Mammalian target of rapamycin; Rapamycin

Indexed keywords

BECLIN 1; CISPLATIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P53; PROTEIN P62; RAPAMYCIN;

ARTICLE; AUTOPHAGY; CELL CULTURE; CELL CYCLE PROGRESSION; CELL DEATH; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIGHT CHAIN; MITOCHONDRIAL MEMBRANE POTENTIAL; NECROSIS; OSTEOSARCOMA; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84884469558     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1531     Document Type: Article

References (28)

1. Raymond AK, Ayala AG and Knuutila S: Conventional osteosarcoma. In: World Health Organization Classification of Tumors. Fletcher CDM, Unni KK and Mertens F (eds). 4th edition. IARC Press, Lyon, France, pp264-270, 2002.
2. Tan JZ, Schlicht SM, Powell GJ, et al: Multidisciplinary approach to diagnosis and management of osteosarcoma-a review of the StVincent's Hospital experience. Int Semin Surg Oncol 3: 38, 2006.
3. Ferrari S and Palmerini E: Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol19: 341-346, 2007.
4. Marcove RC, Miké V, Hajek JV, Levin AG and Hutter RV: Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am52: 411-423, 1970.
5. Akiyama, T, Dass, CR and Choong PF: Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway. Molecular Cancer Ther 7: 3461-3469, 2008.
6. Malicdan MC, Noguchi S, Nonaka I, Saftig P and Nishino I: Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 18: 521-529, 2008.
7. Winslow AR and Rubinsztein DC: Autophagy in neurodegeneration and development. Biochim Biophys Acta 1782: 723-729, 2008.
8. Orvedahl A and Levine B: Eating the enemy within: autophagy in infectious diseases. Cell Death Differ 16: 57-69, 2009.
9. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, etal: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456: 259-263, 2008.
10. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, SatohT, et al: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456: 264-268, 2008.
11. Yen WL and Klionsky DJ: How to live long and prosper: autophagy, mitochondria and aging. Physiology (Bethesda) 23: 248-262, 2008.
12. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
13. Carew JS, Nawrocki ST and Cleveland JL: Modulating autophagy for therapeutic benefit. Autophagy 3: 464-467, 2007.
14. Chen N and Karantza-Wadsworth V: Role and regulation of autophagy in cancer. Biochim Biophys Acta 1793: 1516-1523, 2009.
15. Al-Ejeh F, Kumar R, Wiegmans A, Lakhani SR, Brown MP and Khanna KK: Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes. Oncogene 29: 6085-6098, 2010.
16. Gewirtz DA: Autophagy as a mechanism of radiation sensitization in breast tumor cells. Autophagy 3: 249-250, 2007.
17. John S, Nayvelt I, Hsu HC, Yang P, Liu W, Das GM, et al: Regulation of estrogenic effects by beclin 1 in breast cancer cells. Cancer Res 68: 7855-7863, 2008.
18. Buytaert E, Callewaert G, Vandenheede JR and AgostinisP: Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2: 238-240, 2006.
19. Petronilli V, Miotto G, Canton M, et al: Imaging the mitochondrial permeability transition pore in intact cells. Biofactors8: 263-272, 1998.
20. Moll UM and Zaika A: Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493: 65-69, 2001.
21. Erster S, Mihara M, Kim RH, Petrenko O and Moll UM: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728-6741, 2004.
22. Hirsch T, Marzo I and Kroemer G: Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep17: 67-76, 1997.
23. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004.
24. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S, Sikorska M, et al: Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17: 1595-1607, 1996.
25. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y and KondoS: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457, 2004.
26. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res61: 439-444, 2001.
27. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
28. Kirkin V, McEwan DG, Novak I and Dikic I: A role for ubiquitin in selective autophagy. Mol Cell 34: 259-269, 2009.